Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 1

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis

Total article views   HTML views PDF downloads Totals
4,815 Dovepress* 4,815+ 1,418 6,233
Totals 4,815 1,418 6,233
*Since 15 March 2006
+Since July 2016

View citations on Google Scholar